Aripiprazole in the treatment of Tourette's syndrome.

Trial Profile

Aripiprazole in the treatment of Tourette's syndrome.

Discontinued
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 04 Oct 2011

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Gilles de la Tourette's syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Oct 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 11 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top